Efficacy and safety of GLP-1 receptor agonists in the treatment of obese patients with chronic heart failure: a meta-analysis
The study results show that GLP-1RAs significantly reduce the risk of worsening heart failure events and improve cardiac function, suggesting that GLP-1RAs are promising treatment options for obese patients with CHF.
Authors
- Huimin Lu (ORCID: https://orcid.org/0000-0001-9794-3221)
- Anna Jia
- Tianhong Wang (ORCID: https://orcid.org/0000-0002-0331-3761)
- Yusi Hua (ORCID: https://orcid.org/0000-0003-1640-8388)
- Ming Yang (ORCID: https://orcid.org/0000-0002-2086-1858)
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-10-03
- DOI
- https://doi.org/10.3389/fcvm.2025.1633114
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00